Given that IBD is characterized by increased infiltration of immune cells to the colon, we hypothesized that chemerin signaling plays a proinflammatory role in IBD and that a loss of CMKLR1 would protect against development of the disease. The gene discussed is RARRES2; the disease is inflammatory bowel disease.